TriSalus Life Sciences (TLSIW) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to -$0.96.
- TriSalus Life Sciences' EPS (Weighted Average and Diluted) fell 70000.0% to -$0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.02, marking a year-over-year decrease of 202.02%. This contributed to the annual value of -$1.31 for FY2024, which is 8062.17% up from last year.
- According to the latest figures from Q3 2025, TriSalus Life Sciences' EPS (Weighted Average and Diluted) is -$0.96, which was down 70000.0% from -$0.27 recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' EPS (Weighted Average and Diluted) ranged from a high of $0.09 in Q1 2022 and a low of -$79.38 during Q4 2022
- Its 4-year average for EPS (Weighted Average and Diluted) is -$9.72, with a median of -$0.43 in 2024.
- The largest annual percentage gain for TriSalus Life Sciences' EPS (Weighted Average and Diluted) in the last 5 years was 9946.05% (2023), contrasted with its biggest fall of 4490000.0% (2023).
- TriSalus Life Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$79.38 in 2022, then surged by 98.68% to -$1.05 in 2023, then soared by 59.05% to -$0.43 in 2024, then crashed by 123.29% to -$0.96 in 2025.
- Its last three reported values are -$0.96 in Q3 2025, -$0.27 for Q2 2025, and -$0.39 during Q1 2025.